Ohio Recovery Program Drug Testing: The Regulatory Context

The Ohio Department of Behavioral Health (DBH) oversees the licensure, certification, and quality standards for Ohio's behavioral health treatment system — including substance use disorder treatment programs serving individuals referred through courts, the Ohio Department of Corrections, Medicaid, and community recovery pathways. The Clinical Advisory Group of Ohio's Department of Mental Health and Addiction Services has established guidelines for the appropriate clinical use of urine drug screening for patients with substance use disorder, with frequency guidelines that take into account patient safety, acuity, risk of relapse and overdose, level of care, and sustained abstinence.

For Ohio treatment programs billing through Medicaid or operating under OhioMHAS licensure, urine is the most common specimen to monitor drug use, with two main types: presumptive screening (point-of-care dip cards and cups) and confirmatory testing. Point-of-care dip cards serve as the presumptive screening layer — fast, cost-efficient, and deployable by trained non-laboratory staff at the point of care. Confirmatory testing via a certified laboratory follows any presumptive positive that will be used for a clinical or legal decision.

Which Dip Card Fits Your Recovery Program?

Not every Ohio recovery program has the same testing needs. The right dip card depends on the substances most prevalent in your patient population, the CLIA status required by your program type, and the analytes your clinical team needs to monitor. The SVG chart below maps each dip card configuration to the Ohio recovery settings it serves best.

The Five SAFElife and Healgen Dip Cards for Ohio Recovery Programs

DrugScreens.com carries both the SAFElife T-Dip and Healgen dip card lines for Ohio recovery programs — giving treatment centers the flexibility to choose CLIA-waived options for Medicaid-reimbursable point-of-care screening and forensic-use configurations for fentanyl and alcohol detection. Here is a breakdown of each.

CLIA Waived vs. Forensic Use — What Ohio Programs Must Understand

Four of the five dip cards above are CLIA waived — meaning they can be administered and read by trained non-laboratory staff at the point of care without a CLIA laboratory certificate. This is critical for Ohio treatment programs billing through Medicaid or operating under OhioMHAS certification, where point-of-care presumptive testing documentation must meet CLIA requirements.

The 14-panel Healgen dip card with EtG and fentanyl is Forensic Use Only — not CLIA waived. It provides the fentanyl and alcohol detection capability that no standard CLIA-waived panel currently matches, but it should not be used as the primary device when CLIA-waived documentation is required for Medicaid billing or OhioMHAS compliance records. For programs needing both fentanyl detection and CLIA-waived status, pair a CLIA-waived 10 or 12-panel dip card with a standalone fentanyl dip card add-on.

This content is provided for general informational purposes only and does not constitute legal advice. Any employer or organization considering changes to its workplace or in-house drug screening policies should consult with qualified legal counsel and applicable regulatory authorities before implementing, modifying, or discontinuing any testing program or related procedures.